NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Coty, Inc. (NYSE: COTY) resulting from allegations that Coty may have issued materially misleading business information to the investing public. So What: If you purchased Coty securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Fi. ...

Core Insights - Coty Inc. is under investigation for potential violations of federal securities laws, as announced by Bleichmar Fonti & Auld LLP [1][2] - The investigation arises amid concerns over Coty's reported demand for Prestige fragrances, which constitute 60% of its revenues, while actual retailer inventory levels suggest overstocking due to declining demand [2] Financial Performance - Coty reported disappointing financial results for Q4 and FY 2025, citing issues such as delays in identifying weaknesses in U.S. execution, retailer inventory buildup, and headwinds from previous fiscal year innovations [3] - The company's stock price fell by $1.05, a decline of over 21%, from $4.86 on August 20, 2025, to $3.81 on August 21, 2025, following the release of these results [3]

Core Viewpoint - Coty Inc. is under investigation for potential violations of federal securities laws, following disappointing financial results and claims of overstated demand for its Prestige fragrances [1][2][3]. Group 1: Company Overview - Coty Inc. is one of the largest beauty companies globally, with a diverse portfolio that includes fragrance, color cosmetics, and skin and body care products. Prestige fragrances represent 60% of the company's revenues [2]. Group 2: Financial Performance - On August 20, 2025, Coty reported disappointing financial results for Q4 and FY 2025, citing issues such as weaknesses in U.S. execution, retailer inventory buildup, and challenges from previous fiscal year innovations [3]. - The company's stock price fell by $1.05 per share, a decline of over 21%, from $4.86 on August 20, 2025, to $3.81 on August 21, 2025, following the announcement of these results [3]. Group 3: Market Dynamics - Coty indicated that retailers were maintaining tight inventory levels, while in reality, they were overstocked due to a decline in demand for Coty's products [2]. - The company experienced a slowdown in cosmetics sales attributed to value-seeking consumer behavior, fatigue with innovation, and specific U.S. factors such as in-store security measures and immigration policy changes [3].

Core Insights - Coty Inc. is set to lose the Gucci fragrance license in 2028 to L'Oréal, which has secured a 50-year exclusive license for Gucci's fragrance and beauty products [1][2] - Analysts predict that this loss could significantly impact Coty's financial performance, estimating a 12.5% dilution to total company EBITDA and a 14% dilution to the business excluding the Consumer Beauty assets currently for sale [3] Financial Impact - The Gucci license is estimated to represent approximately 10% of Coty's sales, equating to about $555 million, and around 12% of total adjusted EBITDA, approximately $121 million [5] - If Coty sells its Consumer brands, the Gucci license could account for a larger share, potentially around 14% of company sales and adjusted EBITDA [5] Strategic Considerations - Coty is currently focusing on balancing owned and licensed brands, with 76% of its portfolio being owned or under long-term licenses, while 14% of this is comprised of Gucci [6] - The expiration of the Gucci license poses challenges for Coty in maintaining its revenue and profitability, especially in the current business climate [6] Risk Assessment - Analysts from TD Securities estimate that the expiration of the Gucci license could lead to a negative earnings-per-share impact ranging from -4% to -19% annually for Coty [7]

Core Viewpoint - Coty Inc. is under investigation for potential violations of federal securities laws, following disappointing financial results and claims of overstated demand for its Prestige fragrances [1][2][3]. Group 1: Company Overview - Coty Inc. is one of the largest beauty companies globally, with a diverse portfolio that includes fragrance, color cosmetics, and skin and body care products [2]. - Prestige fragrances represent 60% of Coty's revenues, indicating a significant reliance on this segment [2]. Group 2: Financial Performance - On August 20, 2025, Coty reported disappointing financial results for Q4 and FY 2025, citing issues such as weaknesses in U.S. execution and retailer inventory buildup [3]. - The company's stock price fell by $1.05, a decline of over 21%, from $4.86 to $3.81 per share following the announcement of these results [3]. Group 3: Market Dynamics - Coty claimed strong demand for its Prestige fragrances, but evidence suggests that retailers were actually overstocked due to declining demand for Coty's products [2]. - The company faced a slowdown in cosmetics sales attributed to value-seeking consumer behavior and specific U.S. market challenges [3].

Core Insights - Coty Inc. has initiated a strategic review of specific assets within its Consumer Beauty division, exploring options such as sales, spin-offs, or other strategic transactions [2][3][8] - The review includes Coty's mass color cosmetics portfolio, generating approximately $1.2 billion in annual revenue, and its Brazil business, which contributes close to $400 million in annual revenue [3][8] - The remaining Coty entity aims to strengthen its position in the global fragrance market by integrating its Prestige Beauty and Mass Fragrance businesses, which together account for around 69% of total sales [4][12] Financial Performance - In fiscal year 2025, total revenue fell 3.7% year-over-year to $5.9 billion, with Consumer Beauty revenue declining 8.3% to $2.1 billion [21][22] - The adjusted EBITDA for FY25 decreased by 0.9% year-over-year to $1,082 million, while adjusted net income declined 41.6% to $188.8 million [22][23] - The Consumer Beauty segment's like-for-like revenue declined by 5% in FY25, contrasting with the flat performance of the Prestige fragrance segment [13][19] Strategic Rationale - The strategic review is driven by the underperformance of the Consumer Beauty division compared to the Prestige division, which has seen stronger growth [8][12] - Coty aims to optimize its brand portfolio and focus on higher-margin segments, as the global luxury perfume market is projected to grow from $52 billion in 2025 to $79.5 billion by 2030, representing a CAGR of 8.9% [12][14] - The initiative aligns with the investment strategy of Coty's controlling shareholder, JAB Holding Company, which focuses on divesting noncore assets to enhance value [14][15] Organizational Changes - Coty has appointed Gordon von Bretten as President of the Consumer Beauty division to drive mass cosmetics and personal care businesses [6] - Citibank is advising Coty on potential transaction options, including a spinoff or divestiture [7]

Core Insights - Roche's Genentech is launching a direct-to-consumer sales model for its flu pill, Xofluza, at a discounted price to enhance access for patients [1][2] - The initiative is in response to pressures from the Trump administration to lower drug prices in the U.S. [6] Group 1: Program Details - The new program targets uninsured patients and those with limited or no coverage for Xofluza [2] - Xofluza will be available through three pharmacies with a cash pay option of $50, which is 70% lower than the current list price of over $150 [3][5] - Same-day home delivery is offered in certain markets, with nationwide mail delivery available for those using Xofluza as a preventive treatment [4] Group 2: Market Context - The 2024 to 2025 flu season is projected to be the most severe in over a decade, according to CDC data [2] - The initiative aligns with a broader trend among drugmakers to simplify access to medications amid ongoing scrutiny over drug pricing [1][6]

Core Points - Kylie Jenner, under the moniker "King Kylie," released her first song "Fourth Strike" in collaboration with pop duo Terror Jr, marking a nostalgic return to her earlier public persona [1][3] - The release of the song is part of a broader marketing strategy for the King Kylie Collection of cosmetics, celebrating the 10th anniversary of Kylie Cosmetics, which was valued at over $1 billion in a 2019 deal with Coty Inc [4][8] - The song's music video garnered 366,000 views on Kylie Jenner's YouTube channel shortly after its release [6] Product Launch - The King Kylie Collection will launch on October 18, featuring a new eyeshadow palette, makeup brushes, and returning signature products from the early days of Kylie Cosmetics, such as the "Dead of Night" and "True Brown K" lip kits [7] Financial Background - Kylie Cosmetics was initially valued at $1.2 billion when Jenner sold 51% of the company to Coty for $600 million in 2019, but her billionaire status was later questioned by Forbes, which revised her net worth to under $900 million [8][9]

Core Insights - Coty Inc.'s Consumer Beauty segment experienced a significant downturn in fiscal 2025, with an 8% year-over-year sales decline and a $127 million operating loss, contrasting with a profit from the previous year [1][9] - The adjusted EBITDA margin decreased by 160 basis points to 9.5%, attributed to lower sell-through rates and increased promotional activities [1] Sales Performance - In the fiscal fourth quarter, Consumer Beauty revenues fell by 12%, driven by a high-single-digit decline in sell-out, despite slight overall market growth [2] - The decline was primarily in color cosmetics and body care, while mass fragrances and skincare showed resilience [2] Strategic Focus - Coty is shifting its strategy to prioritize profitability over scale, aiming to enhance the economics of its mass cosmetics platform through tighter spending and innovation in higher-margin subcategories [3] - Recent product launches, such as CoverGirl Yummy Blur lipstick and Rimmel TruBlend Skin Enhancer Balms, have received positive consumer feedback and are intended to leverage momentum in lip and multi-tasking beauty formats [3] Market Trends - The company faces challenges in rekindling consumer interest in makeup as trends shift towards fragrances and simpler beauty routines [4] - The success of Coty's next phase will depend on effective innovation and execution to strengthen the color cosmetics segment within its Consumer Beauty business [4] Stock Performance - Coty shares have increased by 4.1% over the past month, outperforming the broader Consumer Staples sector, which declined by 2.6% [5] - The stock has also surpassed the industry and S&P 500 index growth of 3.6% and 0.4%, respectively, during the same period [5] Valuation Metrics - Coty currently trades at a forward 12-month P/E ratio of 9.74, significantly lower than the industry average of 28.67 and the sector average of 16.33, indicating a modest discount relative to peers [10] Earnings Estimates - The Zacks Consensus Estimate for Coty's earnings per share has been revised downward, with current estimates at 43 cents for the current fiscal year and 47 cents for the next fiscal year [13]

Core Viewpoint - Coty Inc. is undergoing a significant strategic restructuring, focusing on a comprehensive evaluation of its mass beauty business to maximize long-term value and optimize asset allocation [1][2] Group 1: Business Overview - Coty Inc. was founded in 1904 in Paris and operates a range of iconic brands across fragrance, makeup, skincare, and body care, selling in over 120 countries [2] - The mass beauty segment, valued at $1.2 billion, includes brands such as CoverGirl, Rimmel, Sally Hansen, and Max Factor, with a nearly $400 million revenue contribution from Brazil [2][3] Group 2: Financial Performance - For the fiscal year ending June 30, 2025, Coty reported net revenues of $5.893 billion, a year-over-year decline of 3.68%, and a net loss of $381 million, compared to a profit of $76.2 million in the previous year [4] - The mass beauty segment experienced a revenue drop of 8% year-over-year, generating $2.073 billion in the same fiscal year [4][5] Group 3: Market Challenges - The mass beauty business has faced ongoing challenges, including a significant decline in the U.S. market, exacerbated by retailer inventory reductions and overall market pressures [4][5] - Coty has recorded a continuous decline in mass beauty revenues over four consecutive quarters, with Q1, Q2, and Q3 revenues of approximately $555 million, $554 million, and $470 million, respectively, reflecting year-over-year decreases of 3%, 8%, and 9.4% [6] Group 4: Organizational Changes - Coty is implementing organizational changes to integrate its high-end beauty and mass fragrance businesses, which together account for 69% of the company's sales [3][4] - The company has appointed Gordon von Bretten as president of the mass beauty division to explore potential in mass cosmetics, skincare, and personal care, while leading the strategic review [6]